Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SCCHN”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04034225
What this trial is testing

Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Sensei Biotherapeutics, Inc. 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03085719
What this trial is testing

Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 18
Early research (Phase 1)Study completedNCT01334177
What this trial is testing

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+38 more
University of Washington 13
Early research (Phase 1)Study completedNCT02586207
What this trial is testing

Pembrolizumab in Combination With CRT for LA-SCCHN

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+4 more
Sanford Health 59
Testing effectiveness (Phase 2)Ended earlyNCT01111058
What this trial is testing

Everolimus Versus Placebo in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Chicago 52
Large-scale testing (Phase 3)Study completedNCT00995293
What this trial is testing

Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial

Who this might be right for
Head and Neck Neoplasms
Sanofi 240
Testing effectiveness (Phase 2)Study completedNCT00542308
What this trial is testing

Zalutumumab in Non-curable Patients With SCCHN

Who this might be right for
Head and Neck CancerSquamous Cell Cancer
Genmab 90
Very early researchStudy completedNCT04065555
What this trial is testing

Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Presage Biosciences 12
Testing effectiveness (Phase 2)Study completedNCT04046250
What this trial is testing

Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690

Who this might be right for
Mucositis
Tosk, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT00939627
What this trial is testing

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 55
Not applicableStudy completedNCT03880396
What this trial is testing

Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Assiut University 62
Early research (Phase 1)Active Not RecruitingNCT05674526
What this trial is testing

A Phase 1b Study of WU-NK-101 in Combination With Cetuximab

Who this might be right for
Colorectal Cancer MetastaticSquamous Cell Carcinoma of Head and Neck
Allotera Therapeutics 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03468218
What this trial is testing

Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Head and Neck CarcinomaParanasal Sinus Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma+21 more
Emory University 36
Very early researchWithdrawnNCT04891718
What this trial is testing

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Who this might be right for
Solid Tumour
Presage Biosciences
Testing effectiveness (Phase 2)Study completedNCT03878979
What this trial is testing

Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerHead and Neck Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Testing effectiveness (Phase 2)Study completedNCT02057107
What this trial is testing

SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN

Who this might be right for
Previously-IrradiatedSquamous Cell Carcinoma of the Head and Neck Cancer
Heath Skinner 40
Testing effectiveness (Phase 2)Study completedNCT00547157
What this trial is testing

Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
CancerHead and Neck CancerOncology+1 more
Amgen 152
Not applicableStudy completedNCT01080066
What this trial is testing

A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Merck KGaA, Darmstadt, Germany 215
Testing effectiveness (Phase 2)Study completedNCT00371566
What this trial is testing

Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
GlaxoSmithKline 107
Testing effectiveness (Phase 2)Ended earlyNCT02196168
What this trial is testing

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more
National Cancer Institute (NCI) 6
Next Page